CSB-001 Ophthalmic Solution 0.1% Clinical Trials
2 recruitingBiologic
Phase 12
Showing 1–2 of 2 trials
Recruiting
Phase 1
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency
Limbal Stem Cell Deficiency
Claris Biotherapeutics, Inc.75 enrolled6 locationsNCT06452316
Recruiting
Phase 1
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars
Corneal Scar
Claris Biotherapeutics, Inc.20 enrolled7 locationsNCT06257355